Introduction
Periodontitis, a chronic inflammatory disease, begins with a microbial infection, followed by a host-mediated destruction of soft tissue caused by hyperactivated or primed leukocytes and the generation of cytokines, eicosanoids, and matrix metalloproteinases that cause clinically significant connective tissue and bone destruction (1) . Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis are implicated in the pathogenesis of periodontitis (2, 3) . These bacteria are able to produce virulence factors that act locally within the sulcus, and result in tissue destruction (2, 3) . Examples of virulence factors include proteolytic enzymes produced by P. gingivalis and leukotoxins produced by A. actinomycetemcomitans (3) . P. gingivalis has shown e948 the ability to invade human gingival fibroblasts in cell culture while P. gingivalis and A. actinomycetemcomitans have all demonstrated the ability to invade human oral epithelial cells in cell culture (4) . By the way, it is noteworthy that 35% of nosocomial pneumonia has been demonstrated to be related to periodontopathogens (5) . Invasiveness and ubiquitous intraoral distribution may be the main reasons for the reported observation of rather poor results after conventional, merely mechanical treatment of periodontal infections (6) . Thus, adjunctive systemic antibiotics have been advocated in order to suppress the organism in subgingival plaque (7) . The adjunctive use of systemically administered antibiotics has been shown to provide a better clinical outcome, particularly in terms of pocket depth reduction and attachment-level gain, than scaling and root planing in chronic periodontitis subjects (6, 7) . Commonly used antibiotics include clindamycin, metronidazole and amoxicillin (6, 8) . Besides, positive responses have been reported with amoxicillin/clavulanic (6, 8) and moxifloxacin (7) in the treatment of periodontitis. Most of the knowledge available on the microbial composition of subgingival plaque is based on studies from the United States and Europe (8) (9) (10) , where therapeutic oral care programs are available to significant portions of the population. Temporal and geographic changes in antibiotic susceptibility among anaerobes have been reported in Europe (8, 10) . Besides, the development of resistance and significant variation in the local prevalence of resistance are well recognized in aerobic and anaerobic bacteria in Latin America (9) . Determinations of MIC values permit early recognition of emerging resistance. For relevant comparative analysis distributions of the minimal inhibitory concentration (MIC) values are mandatory as the terms susceptible, intermediate and resistant are not universally applicable since breakpoints may vary in different countries (11) . To the best of our knowledge, there are no studies that determine the resistance of A. actinomycetemcomitans and P. gingivalis to a panel of five orally administrable antibiotics in periodontal disease. Thus, the present study aimed to test, in vitro, the susceptibility to different antibiotics of A. actinomycetemcomitans and P. gingivalis isolated from subgingival plaque in periodontal infections.
Study Design
Population studied, clinical evaluation, microbiological sampling and microbiological procedures. A total of 76 adult patients in good general health and with no current medication usage were included in the study after giving informed consent. Medical history and clinical and radiographic examination were conducted for each patient. One of the authors (CA) carried out a complete periodontal examination. The following clinical parameters were recorded: probing depth (PD), clinical attachment level (CAL), and percentages of sites with bleeding on probing (BOP) and plaque. A marked probe (UNC-15, Hu-Friedy, Chicago, IL) was used in all instances. Periodontal diagnosis was established based on the consensus report of the American Academy of Periodontology (AAP) (12) . Subgingival microbial samples were taken from the six deepest pockets. After removing supragingival plaque with curets and isolating the area with cotton pellets, the paper points were inserted into each periodontal pocket for 20 seconds. The paper points (Maillefer, Ballaigues, Switzerland) were pooled in screw cap vials containing Viability Medium Götenborg Anaerobically (VMGA) III medium (13) . All samples were labeled properly and processed within 4 hours after sampling. The samples were analyzed using microbial culture techniques for the presence of periodontopathic bacteria according to Slots (14) . Briefly, most samples were processed at room temperature (25ºC) and incubated in CO 2 and anaerobic culture systems. Brucella blood agar medium was incubated at 35ºC in an anaerobic jar for 7 days. The Trypticicase Soy Serum Bacitracin Vancomycin agar (TSBV) medium was incubated in 10% CO 2 at 37ºC for 4 days. Presumptive identification was performed according to the methods described (14) , and using a commercial identification micromethod system (RapID ANA II, Remel, Norcross, GA, USA) for A. actinomycetemcomitans and P. gingivalis. Total viable counts (TVC) were defined as the total number of colonyforming units obtained on non-selective media plates. Species found on selective media were enumerated and their percentage of TVC was calculated.
Antimicrobial susceptibility testing
The susceptibility/resistance of selected colonies of A. actinomycetemcomitans and P. gingivalis from pure cultures to five antibiotics were measured. The following antimicrobials were tested: clindamycin, metronidazole, amoxicillin, moxifloxacin and amoxicillin/ clavulanic acid (E-test ® , AB Biodisk, Solna, Sweden). Briefly, viable colonies were homogenized in 0.85% saline, and the turbidity was adjusted to MacFarland 1.0 standard (3 x 108 CFU/ml). Using a sterile glass rod, 0.1 ml of the inoculums was spread over Brucella blood agar plates (BD, Sparks, MD, USA) and dried for 15 minutes at room temperature. E-test strips were gently placed onto the agar surface and incubated under anaerobic conditions for 4 days. The elliptic zone of inhibition was examined after 96 hours of incubation. The reading at the intersection of the bacterial zone of inhibition and the E-strip represented the MIC of the organism. The MIC breakpoints were interpreted according to the Clinical Laboratory Standards Institute guidelines (15 
Discussion
The overuse, misuse and widespread prophylactic application of antimicrobial drugs are some of the factors that have led to the emergence of drug resistant microorganisms (11, 16) . Microbial resistance has become a worldwide medical, economic and public health problem although microbial resistance rates are not equally distributed around the world (9) (10) (11) 16) . A. actinomycetemcomitans and P. gingivalis represent two important periodontal pathogens. In this study, we investigated the susceptibility of P. gingivalis and A. actinomycetemcomitans from patients with untreated chronic periodontitis; their invasiveness and ubiquitous intraoral distribution may be the main reasons for the reported observation of poor results after mechanical therapy (6) . Additionally, bacterial resistance to penicillin has become a problem of great clinical significance in Latin America because of its widespread use for many years (11, 16) . In our study, P. gingivalis was highly susceptible to moxifloxacin and amoxicillin/clavulanic acid ( Table 2) . These findings are in agreement with previous studies which have found that P. gingivalis is highly susceptible to these antibiotics (7, 8, 17, 18) . Nevertheless, in our study 23.52%, 21.56% and 25.49% of the isolates were non-susceptible to clindamycin, metronidazole and amoxicillin respectively. Similar results have been reported by other investigations that detected resistances, although lower (19) . In this viewpoint, it is important to note that P. gingivalis has recently been shown to be able of transfer plasmid DNA, chromosomal DNA, or both which would supply a functional system to also transfer resistance determinants (2) . The present findings support that A. actinomycetemcomitans was the least vulnerable microorganisms. Amongst the drugs tested, moxifloxacin and amoxicillin/clavulanic were active against all A. actinomycetemcomitans isolates in vitro ( Table 2 ). Previous studies of the susceptibility of A. actinomycetemcomitans have also shown high susceptibility to these two antibiotics (6-8, 17,18 (16) . Imipenem resistance is due in part to the appearance and dissemination of metallo-β-lactamase enzymes that have been described repeatedly in Latin America (16) . Moreover, an increasing prevalence of penicillin resistant pneumococci has been observed throughout the world, and Latin America echoes this trend (11) .
The results of the present study have shown that moxifloxacin and amoxicillin/clavulanic acid were the most active antibiotics against A. actinomycetemcomitans and P. gingivalis with all the isolates being susceptible. Less effective were clindamycin, metronidazole and amoxicillin. Owing to geographical differences as well as differences over time, we suggest that the overuse and misuse of antibiotics could be influencing the manifestation of more highly resistant strains associated with periodontal infections in our population. Ongoing longitudinal surveillance studies have been crucial to the detection and monitoring of regional antimicrobial resistance patterns, and continue to provide important insights that may serve to modify local prescribing guidelines.
